Laboratory Services

Coagulation Factor V Activity Assay, Plasma

Print this page

Updated Test Information:

Test Description
Coagulation Factor V Activity Assay, Plasma
Synonym(s)

FACTOR V ACTIVITY

Test ID
FACTV
General Information

Useful for:



  • Diagnosing congenital deficiencies (rare) of coagulation factor V

  • Evaluating acquired deficiencies associated with liver disease, factor V inhibitors, myeloproliferative disorders, and intravascular coagulation and fibrinolysis

  • Investigation of prolonged prothrombin time or activated partial thromboplastin time

Specimen Type

Platelet-Poor-Plasma (Citrated)

Specimen Requirements

Light-blue top (3.2% sodium citrate)

Specimen Collection / Processing Instructions

MUST PROCESS WITH 4 HOURS OF COLLECTION
Platelet poor Coag Citrate Specimen processing:
1. Gently invert tube 2-3 times prior to placing in Centrifuge
2. Centrifuge Citrate whole blood at 4500 rpm for 10 minutes
3. Carefully pipette plasma, avoiding the platelet/buffy coat into a plastic vial
4. Centrifuge plasma at 4500 rpm for 10 minutes
5. Pipette the plasma to a plastic vial, leaving the bottom 0.25 mL undisturbed
6. Freeze plasma immediately and transport frozen. 

Minimum Sample Volume

0.5 mL

Additional Processing Details

Patient must not be receiving Coumadin or heparin therapy


Specimen must be collected prior to factor replacement therapy

Stability

Frozen 14 days

Unacceptable Specimen Conditions

  • Gross hemolysis

  • Gross lipemia

  • Gross icterus

Limitations

  • Coagulation testing is highly complex, often requiring the performance of multiple assays and correlation with clinical information. For that reason, consider ordering a Coagulation Consultation.

  • Factor V (labile factor) is highly susceptible to proteolytic inactivation, with the potential for spuriously decreased assay results. In normal individuals, after freeze-thaw of citrate plasma, factor V activity typically may be 10% to 20% less than observed in a fresh plasma specimen, and in occasional individuals, a more marked decrease of factor V activity occurs. Normal results can be regarded as reliable, but decreased factor V activity results need to be correlated with other clinical and laboratory information. Repeat testing may be necessary.

Methodology

Optical Clot-Based

Estimated TAT

1-2 days

Testing Schedule

Monday-Friday

Retention

7 days

CPT Code(s)

85220

Reference Range

> 1 month old: 70-165%
< 1 month old: Normal, full-term newborn infants may have mildly decreased levels (≥ 30% to 35%) which reach adult levels within 21 days 

 

Performing Lab

Mayo

LOINC Code(s)

3193-0

Additional Information